Nile

Barbers, artists help defy vaccine myths for people of color

  • by

A new wave of public health advocacy that is multilingual, culturally sensitive, entertaining and personal is rapidly replacing mundane public service announcements in the battle to stamp out vaccine disinformation circulating in communities of color.

New Research Highlights ‘Surprising’ Findings About COVID-19’s Impact on Mortality in Community, Long-Term Care Settings

  • by

Since last spring, there has been a consistent — and justifiable — narrative that long-term care residents are particularly vulnerable to the deadly COVID-19 virus. New research, however, suggests it’s not so simple. A team of researchers from the Cleveland Clinic and Health Data Analytics… Read More »New Research Highlights ‘Surprising’ Findings About COVID-19’s Impact on Mortality in Community, Long-Term Care Settings

Overnight Health Care: Johnson & Johnson delay prompts criticism of CDC panel | Pfizer CEO says third dose of COVID-19 vaccine ‘likely’ needed within one year | CDC finds less than 1 percent of fully vaccinated people got COVID-19

  • by

Welcome to Thursday’s Overnight Health Care. A researcher at the University of Illinois Urbana-Champaign (UIUC) fought to have her service dog with her in the lab, and even went so far as to outfit him with the same PPE she wore- goggles, boots and…

Andreessen Horowitz-Backed Tomorrow Health Raises $25M, Adds Former Humana CMO to Advisory Board

  • by

Tomorrow Health — a startup that can deliver roughly 40,000 different types of medical supplies into patients’ homes — has raised $25 million in a Series A funding round. The company began operations officially in April of 2020, which was earlier than expected due to… Read More »Andreessen Horowitz-Backed Tomorrow Health Raises $25M, Adds Former Humana CMO to Advisory Board

NH governor will let mask mandate expire on Friday

  • by

New Hampshire Gov. Chris Sununu (R) said Thursday he will not renew the state’s mask mandate, and will let it expire on Friday.”We’ll continue to work with public health to encourage social distancing and wearing of masks when appropriate. That will…

Johnson & Johnson delay prompts criticism for CDC panel

  • by

A Centers for Disease Control and Prevention advisory panel is coming under increased criticism for continuing a pause on the use of the Johnson & Johnson vaccine that is keeping doses on the shelf while the pandemic rages.Many experts backed…

Haffkine Institute gets nod to produce Covaxin

  • by

The Maharashtra government had sought permission from the centre in March seeking the Centre’s nod in getting Haffkine to have a deal with Bharat Biotech to produce Covaxin under a ‘fill and finish basis’ or some other arrangement.

Thermo Fisher to Acquire PPD for $17.4 Billion

  • by

The acquisition, which is expected to be completed by the end of 2021, will give Thermo Fisher access to PPD’s drug development platform, patient recruitment capabilities, and laboratory services.

Fauci, Jim Jordan spar over pandemic restrictions

  • by

A congressional hearing on the pandemic turned personal when Rep. Jim Jordan (R-Ohio) loudly attacked Anthony Fauci, the country’s top infectious disease doctor, about when Americans will be able to stop taking public health precautions like wearing…

C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform

  • by

– Cancer intelligence company, C2i Genomics announced it has raised $100M in financing from Casdin Capital, NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others. – Funds will be used to accelerate clinical development and commercialization of the company’s C2-Intelligence Platform, a… Read More »C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform

Sun Pharmaceutical Industries Ltd-Openings for APM/ PM -Apply Now

  • by

Sun Pharmaceutical Industries Ltd-Openings for APM/ PM -Apply Now Job Description We are Looking for APM/ PM for Gynae Segment Company: Sun Pharmaceutical Industries Ltd Position: APM/ PM Qualification:  B.Pharm + MBA Experience: 2-10 years PMT experience. Location: Mumbai Interested Candidates can Apply On  nilesh.jadhav2@sunpharma.com along with updated resume Click Here… Read More »Sun Pharmaceutical Industries Ltd-Openings for APM/ PM -Apply Now

Tech Innovations: April 2021

  • by

This monthâs roundup of new equipment, materials, digital solutions and other news includes items from Lonza, Waters, Eversana, Clinical Ink, and more.

Hetero -Campus Recruitment for B.Pharm/ M.Pharm/ M.Sc for Freshers On 16th April 2021

  • by

Hetero -Campus Recruitment for B.Pharm/ M.Pharm/ M.Sc for Freshers On 16th April 2021 Job Description We are Conducting Campus Drive for Following..!!! Department: Production/ Quality Posts:  Chemist/ Analyst Qualification: B.Pharm/ M.Pharm/ M.Sc Experience: Freshers Time and Venue Details : Walk-Ins On 16th April 2021 from  09:30 AM , Pydah College of… Read More »Hetero -Campus Recruitment for B.Pharm/ M.Pharm/ M.Sc for Freshers On 16th April 2021

Ipca Laboratories Ltd- Openings for Analyst /Officer-Quality Control-Apply Now

  • by

Ipca Laboratories  Ltd- Openings for Analyst /Officer-Quality Control-Apply Now Company Profile Ipca Laboratories Ltd, A fully integrated pharmaceutical company engaged in the Manufacturing, Marketing and distribution of Active Pharmaceutical Ingredients, pharmaceutical Formulation and medicinal products across the globe. Job Description Raw Material , Packing Material,… Read More »Ipca Laboratories Ltd- Openings for Analyst /Officer-Quality Control-Apply Now

Oscar names new virtual-first care division president

  • by

Dr. Okiki Louis will assume the role of president of Oscar Medical Group at the end of April, heading the New York-based startup’s collection of physician-owned practices, which provide virtual urgent care and primary care.

Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development

  • by

What You Should Know: – Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was… Read More »Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development

Mankind Pharma Limited- Openings for Qualification & Validation/ Maintenance Department -Apply Now

  • by

Mankind Pharma Limited- Openings for Qualification & Validation/ Maintenance Department -Apply Now Job Description We are looking for young and Dynamic personnel from Pharma Background with proven track records, who have exposure to advance regulated market operations (USFDA) for OSD, Sterile Injectable & Ophthalmic Products… Read More »Mankind Pharma Limited- Openings for Qualification & Validation/ Maintenance Department -Apply Now

Buchanan to seek top GOP position on Ways and Means Committee

  • by

Rep. Vern Buchanan (R-Fla.) announced Thursday that he is running to be the top Republican on the House Ways and Means Committee in the next Congress, seeking to lead the powerful panel with jurisdiction over tax, trade and health issues.The…

Worries grow over GOP reluctance to take vaccines

  • by

Two polls released this week gauging support for receiving the coronavirus vaccine are underscoring the lingering hesitancy many Republicans still harbor toward the shots, fueling concerns over an unstable recovery from the pandemic.A poll from…

Merck Keeps Plowing On

  • by

I last wrote about the small-molecule antiviral malnupiravir here, and we finally have more information from Merck and Ridgeback about its effects in clinical trials. An interim analysis of the Phase II data from trials in both outpatients and in hospitalized coronavirus patients has been… Read More »Merck Keeps Plowing On

Busted: The top healthcare fraud schemes of Q1 2021

  • by

While 2021 has brought renewed optimism over the COVID-19 pandemic, it has also delivered numerous new fraud, waste, and abuse (FWA) cases in healthcare. From billing inaccurate procedures learned via YouTube to defrauding a fund intended to help those with traumatic brain injuries, bad actors continue to find new ways to increase their reimbursement at the expense of… Read More »Busted: The top healthcare fraud schemes of Q1 2021

Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19

  • by

Zach Henderson, Chief Commercial Officer, Glooko As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an estimated 80% of non-COVID-19 trials—came to a halt or were interrupted by the… Read More »Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19

Boehringer Ingelheim and MD Anderson Expand their Collaboration to Accelerate Targeted Therapies for Lung Cancer

  • by

Shots: Boehringer Ingelheim and MD Anderson expand their 2019 joint VRDC to explore new molecules from Boehringer Ingelheim’s KRAS and TRAILR2 portfolios for lung cancer, particularly NSCLC The joint research will continue for 5 additional years. The extended collaboration follows successful preclinical studies in GI… Read More »Boehringer Ingelheim and MD Anderson Expand their Collaboration to Accelerate Targeted Therapies for Lung Cancer

7wireVentures & EHIR Partner to Accelerate the Adoption of Digital Health Solutions

  • by

What You Should Know: – 7wireVentures, an early-stage digital health venture capital firm, and Employer Health Innovation Roundtable (EHIR), a coalition of the largest and most progressive employers, health plans, and health systems are announcing a partnership to accelerate digital health innovation and improve consumer health,… Read More »7wireVentures & EHIR Partner to Accelerate the Adoption of Digital Health Solutions

BMS’ Opdivo (nivolumab) + Cabometyx (cabozantinib) Receive EC’s Approval for 1L Treatment of Advanced Renal Cell Carcinoma

  • by

Shots: The approval is based on P-III CheckMate -9ER trial involves assessing Opdivo + Cabometyx vs sunitinib in 651 patients with previously untreated advanced or metastatic RCC Results: @median follow-up of 10.6 mos.; m-PFS (16.6 vs 8.3mos.), ORR (55.7% vs 27.1%); CR (9.3% vs 4.3%);… Read More »BMS’ Opdivo (nivolumab) + Cabometyx (cabozantinib) Receive EC’s Approval for 1L Treatment of Advanced Renal Cell Carcinoma

Medtronic Launches World’s First Extended Insulin Infusion Set to Reduce Burden for People with Diabetes in Europe

  • by

Shots: Medtronic launches a new insulin infusion set that can be worn for up to 7days. The infusion set is compatible with all MiniMed 600 and 700 series insulin pumps The extended infusion set utilizes advanced materials that help in reducing insulin preservative loss and… Read More »Medtronic Launches World’s First Extended Insulin Infusion Set to Reduce Burden for People with Diabetes in Europe

Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation

  • by

When it comes to developing cutting-edge innovations, Astellas aims to be at the forefront. The pharma organisation prides itself on having an open, collaborative, “science first” approach to help ensure breakthrough discoveries have the very best chance of long-term success in bringing new treatment options… Read More »Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation

Genentech Presents Results of Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA at AAN2021

  • by

Shots: The 2-year data from Part 2 of P-II/III FIREFISH study involves assessing Evrysdi in 41 infants aged 1-7mos. with symptomatic Type 1 SMA Results: improvement in maintained motor function b/w 12-24mos., babies were able to sit without support for at least 5sec. after 24mos.… Read More »Genentech Presents Results of Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA at AAN2021

AstraZeneca Collaborates with Sanguina to Develop AnemoCheck App for Hemoglobin Management in Patients with Anemia of CKD

  • by

Shots: The companies collaborated to develop a custom version of AnemoCheck Mobile to measure Hgb levels in patients with anemia of CKD AnemoCheck app can measure Hgb levels using a single photo of a user’s fingernail applying an algorithm based on the pallor of a… Read More »AstraZeneca Collaborates with Sanguina to Develop AnemoCheck App for Hemoglobin Management in Patients with Anemia of CKD

Biophore India Pharmaceuticals Pvt. Ltd-Openings for Young & Talent Acquisition Professional for R&D Center

  • by

Biophore India Pharmaceuticals Pvt. Ltd-Openings for Young & Talent Acquisition Professional for R&D Center Greetings from Biophore India Pharmaceuticals Pvt. Ltd!!! Looking for Young and Energetic Talent Acquisition Professional for our Research and Development center based in Hyderabad. Job Description End to end Recruitment Process.… Read More »Biophore India Pharmaceuticals Pvt. Ltd-Openings for Young & Talent Acquisition Professional for R&D Center

Eli Lilly Signs an Exclusive License Agreement with SciNeuro to Develop and Commercialize Alpha-synuclein Targeted Therapies in China

  • by

Shots: Lilly to receive up front, milestones, as well as royalties on the products developed and commercialize by SciNeuro. Lilly retains all rights outside Greater China SciNeuro to get an exclusive license to develop and commercialize alpha-synuclein targeted therapies in Greater China includes mainland China,… Read More »Eli Lilly Signs an Exclusive License Agreement with SciNeuro to Develop and Commercialize Alpha-synuclein Targeted Therapies in China

The Fascinating History of the Color Red

  • by

The Fascinating History of the Color Red The color red was most likely the first color (besides black and white) to be registered in our ancient ancestors brains. The Doctor Weighs In

Michigan expands antibody treatment to cut hospitalizations

  • by

The drugs, delivered intravenously and made by Regeneron Pharmaceuticals and Eli Lily, have concentrated doses of lab-made antibodies to fight COVID-19 and are geared toward people who are at high risk for severe symptoms or having to be hospitalized.

J&J vaccine to remain in limbo while officials seek evidence

  • by

At an emergency meeting, advisers to the Centers for Disease Control and Prevention wrestled with the fact that the U.S. has enough alternative shots to vaccinate its population but other countries anxiously awaiting the one-and-done vaccine may not.

Anthem, K Health, Blackstone launch digital health company

  • by

The new joint venture will bring K Health’s artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their symptoms and connect with a doctor if needed.

Medtronic Launches World’s First 7-Day Wear Infusion Set to Reduce Burden for People with Diabetes

  • by

What You Should Know: – Medtronic has announced the launch of the world’s first and only infusion set that can be worn for up to seven days (instead of the typical three) in select European countries. The infusion set is responsible for delivering insulin from… Read More »Medtronic Launches World’s First 7-Day Wear Infusion Set to Reduce Burden for People with Diabetes

Public health, racial equity, climate action drive Biden’s budget requests for healthcare

  • by

President Joe Biden has submitted his discretionary budget for 2022 to Congress. Among its healthcare provisions are funding requests for the CDC, mental health and social determinants of health programs. But there are some unusual requests as well, such as funding for an Office of… Read More »Public health, racial equity, climate action drive Biden’s budget requests for healthcare

CMS issues new guidance to enforce price transparency rule

  • by

CMS issued new guidance on Github for “developers and consumers of the machine-readable files required through the Transparency in Coverage rule” after an investigation into hospital pricing websites revealed hundreds were using code to block information from showing up on search engines.

In MedCity Pivot podcast, Glen Tullman says other care navigation firms aren’t really taking risks

  • by

Livongo’s founder has created a new care navigation venture because he believes that both the experience that people undergo as they look for care and the level of risk that vendors are willing to take when they work with self-insured employers leave much to be… Read More »In MedCity Pivot podcast, Glen Tullman says other care navigation firms aren’t really taking risks

Cleveland Clinic researchers measure pandemic’s effect on Medicare population

  • by

Research conducted by the Cleveland Clinic and Massachusetts-based startup Health Data Analytics Institute (HDAI) measured the difference in mortality during the pandemic  between people covered by Medicare in long-term care facilities and in the community. While a Covid-19 diagnosis increased deaths in both settings, there… Read More »Cleveland Clinic researchers measure pandemic’s effect on Medicare population